The future of CML treatment and cures
Interim results of pegylated interferon alpha-2a for polycythemia vera and essential thrombocythemia
The role of transplant in the era of new treatments for lymphoma and CLL
Results of Phase Ib/II study of ricolinostat in multiple myeloma
What does the TOURMALINE-MM2 study tell us about the use of ixazomib in multiple myeloma?